AI assistant
Innoviva, Inc. — Director's Dealing 2011
May 12, 2011
32090_dirs_2011-05-12_d12c1b95-7579-41d0-9d9c-c68da9ef5d0b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2011-05-10
Reporting Person: Winningham Rick E (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-05-10 | Common Stock | S | 54646 | $26.41 | Disposed | 559006 | Direct |
| 2011-05-11 | Common Stock | S | 73100 | $26.28 | Disposed | 485906 | Direct |
Footnotes
F1: Dispositions made pursuant to a plan intended to comply with rule 10b5-1(c).
F2: This transaction was executed in multiple trades at prices from $26.21 to $26.55. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.
F3: This transaction was executed in multiple trades at prices from $25.97 to $26.79. The price reported above reflects the weighted average sale price.